Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Supplementation for Exercise at High Altitude
NCT05798416Completed
- Sponsor
- State Key Laboratory of Respiratory Disease
- Start
- Feb 2023
- Primary completion
- Apr 2023
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of Carbon dioxide in acute mountain sickness (AMS) and hypoxia (2 arms), sponsored by State Key Laboratory of Respiratory Disease. Primary endpoint: Change of the distance in walking test at 48 hours. Started Feb 2023; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
acute mountain sickness (AMS)hypoxia
Beyond the preview
Go deeper on NCT05798416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05798416.